Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - Chronic Obstructive Pulmonary Disease
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

patient care perspectives

Management of Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria

Management of Breakthrough Hemolysis in Paroxysmal Nocturnal Hemoglobinuria

patient care perspectives
By Vahid Afshar-Kharghan, MD

Real-World Factors Associated With BTK Inhibitor Discontinuation in Chronic Lymphocytic Leukemia

Real-World Factors Associated With BTK Inhibitor Discontinuation in Chronic Lymphocytic Leukemia

patient care perspectives
By Ian W. Flinn, MD, PhD

Approach to the Treatment of Younger Patients With Chronic Lymphocytic Leukemia

Approach to the Treatment of Younger Patients With Chronic Lymphocytic Leukemia

patient care perspectives
By Kerry A. Rogers, MD

Personalizing the Treatment of Anemia in Patients With Lower-Risk MDS

Personalizing the Treatment of Anemia in Patients With Lower-Risk MDS

patient care perspectives
By Rami S. Komrokji, MD

Long-term Monitoring of Patients With Paroxysmal Nocturnal Hemoglobinuria

Long-term Monitoring of Patients With Paroxysmal Nocturnal Hemoglobinuria

patient care perspectives
By David Dingli, MD, PhD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?